NAVIDEA BIOPHARMACEUTICALS, INC. SEC filing history

949 loaded recent SEC filings. No local filings are indexed for this CIK yet. This fallback shows up to 1,000 recent submissions, not the complete SEC archive.

Open complete filing history at SEC

SEC filing history

Showing 751–775 of 949 matching filings.

Per page
25
Current page
31
4

4 filing

Filing date
14 Sep 2012
Reporting date
14 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Sep 2012
Reporting date
11 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Sep 2012
Reporting date
15 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Sep 2012
Reporting date
12 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
12 Sep 2012
Reporting date
10 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
06 Sep 2012
Reporting date
31 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-168485

EFFECT filing

Filing date
30 Aug 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-156810

EFFECT filing

Filing date
30 Aug 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
30 Aug 2012
Reporting date
27 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-168485

POST-EFFECTIVE AMENDMENT TO S-3

Filing date
30 Aug 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-156810

POST-EFFECTIVE AMENDMENT TO S-3

Filing date
30 Aug 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
20 Aug 2012
Reporting date
14 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-183317

REGISTRATION STATEMENT

Filing date
15 Aug 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
07 Aug 2012
Reporting date
06 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
06 Aug 2012
Reporting date
31 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
31 Jul 2012
Reporting date
25 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-43603

PLATINUM PARTNERS VALUE ARBITAGE FUND SC 13G 4-2-2012

Filing date
27 Jul 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-35076

AUTO-GENERATED PAPER DOCUMENT

Filing date
11 Jul 2012
Reporting date
31 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35076

FORM DEF 14A

Filing date
10 Jul 2012
Reporting date
14 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
07 Jun 2012
Reporting date
01 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-43603

PLATINUM-MONTAUR LIFE SCIENCES, LLC SC 13DA #2 4-2-2012 (NAVIDEA BIOPHARMACEUTIC

Filing date
04 Jun 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
03 May 2012
Reporting date
02 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Apr 2012
Reporting date
20 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .